CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating activities
Net loss	$ (101,879)	$ (71,735)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,238	4,821
Equity-based compensation	13,856	21,838
Change in fair value of warrant liability	33,177	4,101
Change in fair value of Asset Purchase Agreement liability	(966)
Realized and unrealized gain on marketable securities	(888)	(546)
Equity method investment loss	175	191
Asset retirement obligation accretion	76	66
Amortization of debt discount	6,174	3,151
Changes in operating assets and liabilities:
Accounts receivables	(969)	(164)
Other current assets	388	537
Other assets	110	119
Accounts payable	467	(627)
Deferred revenue	(9)	202
Accrued expenses and other liabilities	5,990	1,884
Operating lease right-of-use assets and liabilities	1,052	722
Net cash used in operating activities	(38,008)	(35,440)
Investing activities
Capitalization of costs and purchases of network assets, property, and equipment	(350)	(2,751)
Purchase of internal use software	(442)	(983)
Purchase of marketable securities	(82,443)	(37,441)
Sale and maturity of marketable securities	46,500	42,249
Payment for Asset Purchase Agreement liability	(2,732)
Net cash provided by (used in) investing activities	(39,467)	1,074
Financing activities
Proceeds from senior secured notes		70,000
Payments towards debt issuance cost		(1,861)
Payments towards debt	(111)	(110)
Proceeds from exercise of common stock options	3,787	73
Proceeds from exercise of common warrants	31,387	882
Redemption of non-controlling interests	40
Net cash provided by financing activities	35,103	68,984
Effect of exchange rates on cash and cash equivalents	(176)	30
Net increase (decrease) in cash and cash equivalents	(42,548)	34,648
Cash and cash equivalents at beginning of period	81,878	47,230
Cash and cash equivalents at end of period	39,330	81,878
Non-cash investing and financing information and supplemental disclosures
Capital expenditure included in Accrued expenses and other current liabilities	78	285
Reclassification of warrant liability to common stock warrants	11,523	1,248
Issuance of warrants		22,843
Interest paid in shares	3,842	1,888
Interest paid in cash	3,502	1,808
Income taxes paid, net	$ 195	$ 147